Stochastic modelling of tyrosine kinase inhibitor rotation therapy in chronic myeloid leukaemia.

Drug rotation therapy might be able to delay the onset of resistance in CML patients without costly ongoing observation of mutation status. Moreover, the simulations give credence to the suggestion that lower drug concentrations may achieve better results following major molecular response in CML.